Tianjin Chase Sun Pharmaceutical Co.,Ltd

XSEC:300026 Stock Report

Market Cap: CN¥12.2b

Tianjin Chase Sun PharmaceuticalLtd Future Growth

Future criteria checks 3/6

Tianjin Chase Sun PharmaceuticalLtd is forecast to grow earnings and revenue by 34.4% and 8.9% per annum respectively. EPS is expected to grow by 33% per annum. Return on equity is forecast to be 6.3% in 3 years.

Key information

34.4%

Earnings growth rate

33.0%

EPS growth rate

Pharmaceuticals earnings growth18.5%
Revenue growth rate8.9%
Future return on equity6.3%
Analyst coverage

Low

Last updated17 May 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300026 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20267,083664N/A6291
12/31/20256,511557N/A4311
12/31/20246,194533N/A7151
9/30/20245,6271667381,043N/A
6/30/20245,6823091,1021,417N/A
3/31/20245,9133899801,309N/A
12/31/20236,1095071,1831,530N/A
9/30/20236,6726631,1121,485N/A
6/30/20236,762617382911N/A
3/31/20236,577561269928N/A
1/1/20236,650624-25745N/A
9/30/20227,084521-538262N/A
6/30/20227,496602-258497N/A
3/31/20227,764732-317418N/A
12/31/20217,671687-286392N/A
9/30/20217,266611111717N/A
6/30/20217,192667-173395N/A
3/31/20217,001657-162364N/A
12/31/20206,488573-367197N/A
9/30/20206,109485-753-148N/A
6/30/20205,497396-563100N/A
3/31/20205,085337-519149N/A
12/31/20195,003403-375216N/A
9/30/20194,796264-221247N/A
6/30/20194,548216-253147N/A
3/31/20194,303219-101225N/A
12/31/20184,22421193388N/A
9/30/20184,015463297593N/A
6/30/20183,894514N/A805N/A
3/31/20183,605485N/A865N/A
12/31/20173,374451N/A742N/A
9/30/20173,543633N/A610N/A
6/30/20173,564630N/A590N/A
3/31/20173,743666N/A472N/A
12/31/20163,867659N/A448N/A
9/30/20163,722582N/A362N/A
6/30/20163,635599N/A251N/A
3/31/20163,596572N/A108N/A
12/31/20153,348535N/A121N/A
9/30/20153,187541N/A193N/A
6/30/20153,076474N/A115N/A
3/31/20152,969452N/A220N/A
12/31/20142,864447N/A150N/A
9/30/20142,681421N/A105N/A
6/30/20142,405395N/A110N/A
3/31/20142,201362N/A93N/A
12/31/20132,097340N/A144N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300026's forecast earnings growth (34.4% per year) is above the savings rate (2.8%).

Earnings vs Market: 300026's earnings (34.4% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 300026's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300026's revenue (8.9% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 300026's revenue (8.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300026's Return on Equity is forecast to be low in 3 years time (6.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y